Sandbox GGC3

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (17:06, 28 April 2021) (edit) (undo)
 
(102 intermediate revisions not shown.)
Line 1: Line 1:
-
==Spike glycoprotein==
+
==Firefly Luciferase==
-
<StructureSection load='6VSB' size='340' side='right' caption='3D representation of the Spike glycoprotein' scene=''>
+
-
3D structure representation of the Spike glycoprotein related to the SARS-CoV-2 <ref>DOI 10.1002/ijch.201300024</ref> <ref>PMID:21638687</ref>.
+
-
==Introduction==
+
<StructureSection loadfiles='4G36''4G37' size='340' side='right' caption='Luciferin-4-monooxygenase. The wild-type luciferase in the adenylate-forming conformation with DLSA (PDB 4G36) and the cross-linked luciferase in the second catalytic conformation with DLSA (PDB 4G37)' scene=''>
-
The Spike protein is related to the novel coronavirus pandemic discovered in 2019. The virus is named as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and it belongs to the β coronavirus family. The SARS-CoV-2 is a single stranded RNA with 29,881bp length, which encodes for 9860 amino acids. It is compose of two proteins: the structural and non-structural proteins. The structural proteins are S,E,M and N ; whiles as the non-structural proteins are encoded on the ORF regions<ref>Huang, Y., Yang, C., Xu, X., Xu, W., & Liu, S. (2020). Structural and functional properties of SARS-CoV-2 spike protein: Potential antivirus drug development for COVID-19. Acta Pharmacologica Sinica, 41(9), 1141-1149. doi:10.1038/s41401-020-0485-4</ref>.
+
Firefly luciferase, of the common eastern firefly (''Photinus pyralis''), is responsible for the ability of the firefly to exhibit bioluminescence. The enzyme luciferin-4-monoxygenase, which catalyzes a multistep oxidative decarboxylation of the luciferyl-AMP intermediate (LH<sub>2</sub>-AMP) to produce bioluminescence, is a part of the ANL superfamily named so after the '''a'''cyl-CoA syntheses, the adenylation domains of the modular '''n'''on-ribosomal peptide synthetases (NRPs), and '''l'''uciferase.
-
+
-
==The Spike Protein==
+
== Function ==
-
The S-protein is a structural protein extends from the viral membrane and it is uniformly arranged as a trimer on the surface to give the crown-like appearance of the SARS-Co
+
[[Image:Common_Eastern_Firefly.jpg|thumb|left|upright=1.1|The Common Eastern Firefly in a hand emitting a yellow hue, showing bioluminescence.[https://www.wnpr.org/post/how-chemistry-behind-fireflys-glow-could-lead-innovations-medicine]]]
-
V-2. The Spike protein is 14-1255bp long, which mediates a receptor binding Val367<scene name='75/752266/Val367/1'>Binding region val367</scene> and fusion of the virus and a cellular membrane <ref>Mohammad, A., Alshawaf, E., Marafie, S. K., Abu-Farha, M., Abubaker, J., & Al-Mulla, F. (2020). Higher binding affinity of Furin to SARS-CoV-2 spike (S) protein D614G could be associated with higher SARS-CoV-2 infectivity. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, S1201-9712(20)32237-2. Advance online publication. https://doi.org/10.1016/j.ijid.2020.10.033</ref>. Is also gives the virus its name in Latin as "Corona".
+
The ANL enzymes catalyze two-step reactions: the first an adenylating step in which an acyl-AMP intermediate is produced; the second step in which the adenylate then serves as a substrate for the multistep oxidative decarboxylation of the luciferyl-AMP (LH<sub>2</sub>-AMP) intermediate, resulting in bioluminescence.
-
==Domains==
+
ANL enzymes follow a domain alternation strategy for the first adenylation reaction, in which the reaction is catalyzed by <scene name='75/752266/4g36/2'>one conformation</scene>, and following the formation of the adenylate intermediate and release of pyrophosphate (PPi), the C-terminal domain undergoes a rotational transformation that is necessary for <scene name='75/752266/4g37/2'>the second partial reaction</scene>. The <scene name='75/752266/Active_site/1'>active site</scene><ref name=“Branchini”>Branchini, B. R., Magyar, R. A., Murtiashaw, M. H., Anderson, S. M., Helgerson, L. C., & Zimmer, M. (1999). Site-directed mutagenesis of firefly luciferase active site amino acids: a proposed model for bioluminescence color. ''Biochemistry 38''(40), 13223–13230. https://doi.org/10.1021/bi991181o</ref> of ANL enzymes resides between a 400-500 residue N-terminal domain and a smaller C-terminal domain of ~110-130 amino acids<ref name="Sundlov">Sundlov, J. A., Fontaine, D. M., Southworth, T. L., Branchini, B. R., & Gulick, A. M. (2012). Crystal Structure of Firefly Luciferase in a Second Catalytic Conformation Supports a Domain Alternation Mechanism. ''Biochemistry 51''(33), 6493-6495. https://doi.org/10.1021/bi300934s</ref>. Ten conserved regions of these proteins have been termed the A1-A10 motifs which play critical roles in either or both partial reactions<ref name="Marahiel">Marahiel, M. A., Stachelhaus, T., & Mootz, H. D. (1997). Modular Peptide Synthetases Involved in Nonribosmal Peptide Synthesis. ''Chemical Reviews 97''(7), 2651-2674. https://doi.org/10.1021/cr960029e</ref>. Two lysine residues are required for each partial reaction, suggestive that luciferase similarly adopts a rotational transformation for complete catalysis. A mutation of <scene name='75/752266/Lys529/1'>Lys529</scene>, the A10 lysine, impairs only the initial adenylation reaction<ref name="Sundlov"/> whereas mutation of <scene name='75/752266/Lys443/1'>Lys443</scene> in the A8 region disrupts the oxidative reaction<ref name="Sundlov"/>.
-
The S-protein of the SARS-CoV-2 has two main subunits , an S1 and S2 subunits NTD-CT<scene name='75/752266/Ntd_-_ct/1'>S1 subunit is in the downstream of NTD and S2 subunit is in the upsteam of CT</scene> . The S1 subunit is located on residue #14–685 ( contains the NTD, blue label) and interact with human AEC2 by attaching its virion to the cell membrane by interacting with host receptor. The S2 subunit is located on residue #686–1273 ( contains the CT, red label ) which serves as the fusion protein of the virus <ref>UniProt ConsortiumEuropean Bioinformatics InstituteProtein Information ResourceSIB Swiss Institute of Bioinformatics. (2020, October 07). Spike glycoprotein. Retrieved November 13, 2020, from https://www.uniprot.org/uniprot/P59594</ref>.
+
-
+
-
==Activation of S-protein==
 
-
Before the Spike protein can be activated , it has to be cleaved by the protease Furin protein ALA 668 <scene name='75/752266/Ala_668/1'>Furin Cleavage site</scene> . This 2D image below shows the schematic cleavage of the S-protein before and after it enters the host cell
 
-
[[Image:Cleavage.jpg]] <ref>Shang, J., Wan, Y., Luo, C., Ye, G., Geng, Q., Auerbach, A., &amp; Li, F. (2020, May 26). Cell entry mechanisms of SARS-CoV-2. Retrieved November 14, 2020, from https://www.pnas.org/content/117/21/11727</ref>
 
 +
=== Biochemical Mechanism of LH2-AMP Oxidation===
-
==The Mechanism of the Spike Protein==
+
[[Image:Mechanism_of_Firefly_Bioluminescence.png|thumb|upright=2.3|The generally accepted mechanism of firefly bioluminescence. The first reaction (1) involves the production of an luciferyl-adenylate intermediate. The second reaction (2) involves oxidative decarboxylation that emits CO<sub>2</sub> and results in bioluminescent properties<ref name="Sundlov"/>.]]
-
LYS 187 <scene name='75/752266/Lys_187/1'>The Receptor Binding Domain (RBD)</scene>
+
-
[[Image:Picture3.jpg]]<ref>doi:10.1038/s41401-020-0485-4</ref>
+
The first partial reaction entails the conversion of the carboxyl group of <small>D</small>-luciferin<ref name="Sundlov"/><ref name="Bruce">Branchini, B. R., Southworth, T. L., Murtiahsaw, M. H., Wilkinson, S. R., Khattak, N. F., Rosenberg, J. C., & Zimmer, M. (2005). Mutagenesis Evidence that the Partial Reactions of Firefly Bioluminescence are Catalyzed by Different Conformations of the Luciferase C-Terminal Domain. “Biochemistry 44”(5), 1385-1393. https://doi.org/10.1021/bi047903f</ref><ref name="Nakamura">Nakamura, M., Maki, S., Amano, Y., Ohkita, Y., Niwa, K., Hirano, T., Ohmiya, Y., & Niwa, H. (2005). Firefly luciferase exhibits bimodal action depending on the luciferin chirality. “Biochemical and Biophysical Research Communications, 331”(2), 471–475. https://doi.org/10.1016/j.bbrc.2005.03.202</ref> by luciferase in the presence of ATP and Mg<sup>2+</sup>, yielding luciferyl-adenylate (LH<sub>2</sub>-AMP) and pyrophosphate as a by-product. Amino acid residues subsequently are recruited to promote the oxidation of LH<sub>2</sub>-AMP using molecular oxygen by luciferase (acting as a monooxygenase)<ref name="Oba">Oba, Y., Ojika, M., & Inouye, S. (2003). Firefly luciferase is a bifunctional enzyme: ATP-dependent monoxygenase and a long chain fatty acyl-CoA synthetase. “FEBS Letters 540”(1-3), 251-254. https://doi.org/10.1016/S0014-5793(03)00272-2</ref>, which then eventually yields oxyluciferin in the excited-state and CO<sub>2</sub>. It is upon the return from the excited-state to the ground state that the emittance of a yellow-green light is observed (λ≈560 nm)<ref name="Nakamura"/>.
 +
An alternative mechanism involving the enantiomer of <small>D</small>-luciferin exists, though typically <small>L</small>-luciferin acts as a competitive inhibitor to the bioluminescence-producing reaction<ref name=“Seliger”>Seliger, H. H., McElroy, W. D., White, E. H., & Field, G. F. (1961). Stereospecificity and firefly bioluminescence, a comparison of natural and synthetic luciferins. ‘’Proceedings of the National Academy of Sciences of the United States of America 47’’(8), 1129-1134. https://doi.org/10.1073/pnas.47.8.1129</ref>, though accounts of light production in small quantities have previously been reported<ref name=“Lembert”>Lembert, N. (1996). Firefly luciferase can use L-luciferin to produce light. ‘’Biochemical Journal 317’’(1), 273-277. https://doi.org/10.1042/bj3170273</ref>. The mechanism by which <small>L</small>-luciferin acts as the substrate in the presence of luciferase (and ATP and Mg<sup>2+</sup>) is the same in the first partial reaction, with both producing the intermediate luciferyl-adenylate. Rather than the oxidative decarboxylation step, the adenyl group (AMP) is substituted with CoA-SH yielding luciferyl-CoA. Furthermore, the stereospecificity of luciferase has shown that even in the presence of CoA-SH, <small>D</small>-luciferin was not converted into luciferyl-CoA but proceeded in being used for the emittance of light<ref name="Nakamura"/>.
-
==Mutation==
 
-
The most studied mutation site of the S-protein is at residue 614 which encodes for the amino acid Aspartic acid (D) D614 <scene name='75/752266/Asp_614/1'>The Mutation site D614 </scene> and is normally changed to Glycine (G). And this form of mutation causes the enhancement of the viral transmission <ref>doi.org/10.1016/j.ijid.2020.10.033</ref>.
 
-
 
 +
== Structural highlights ==
 +
[[Image:DLSA.png|thumb|right|upright=2.3|5'-O-[N-(Dehydroluciferyl)-sulfamoyl] adenosine, shortened to DLSA for brevity. The sulfamate moiety is shown to the far left (sulfur atoms are represented in yellow while oxygen atoms are represented in red). Further, the carbonyl oxygen of the luciferyl-adenylate is connected to the sulfamate moiety via nitrogen atom (represented in blue). [https://pubchem.ncbi.nlm.nih.gov/compound/5_-O-_N-_Dehydroluciferyl_-sulfamoyl_-adenosine]]][[Image:Dihedral-angles-anim.gif|thumb|left|upright=5.1|The φ(Phi)/ψ(Psi) angles of the Lys439 residue undergo a rotational transformation of −73°/−12° to −69°/158° in the adenylate-forming to second-catalytic conformation, respectively, showing that the major torsional change in the ψ angle is observed<ref name="Sundlov"/>.]]
 +
The conserved catalytic lysine for the adenylation reaction<ref name="conserved">Branchini, B. R., Murtiashaw, M. H., Magyar, R. A., Anderson, S. M. (2000). The Role of Lysine 529, a Conserved Residue of the Acyl-Adenylate-Forming Enzyme Superfamily, in Firefly Luciferase. ''Biochemistry 39''(18), 5433-5440. https://doi.org/10.1021/bi9928804</ref>, Lys529, <scene name='75/752266/Nlys529oogly316/1'>interacts</scene> with the carbonyl oxygen of the adenylate, the O5 atom that bridges the ribose and sulfamate moiety, and the main chain carbonyl of Gly316. The second conformation observations show that the <scene name='75/752266/N_lys443/1'>side chain amine</scene> of Lys443 adopts a nearly identical position as Lys529, and Gln448 of the C-terminal domain rotates into the binding pocket where it <scene name='75/752266/Gln448ando/1'>interacts</scene> with a sulfamate oxygen<ref name="Sundlov"/><ref name="Bruce"/>. Altogether (with the inclusion of an <scene name='75/752266/Glu479andarg437/1'>ionic interaction</scene> between Glu479 and Arg437), these interactions are responsible for the stabilization of the new C-terminal conformation.
-
== Structural highlights ==
 
-
These are the structural 3D representations of the s-protein showing the two subunits , the binding regions to its receptor human ACE2 , Mutation site , RBD site and cleavage site respectively. NTD-CT<scene name='75/752266/Ntd_-_ct/1'>S1 subunit is in the downstream of NTD and S2 subunit is in the upsteam of CT</scene> .Val367<scene name='75/752266/Val367/1'>Binding region val367</scene> . D614 <scene name='75/752266/Asp_614/1'>The Mutation site D614 </scene>. LYS 187 <scene name='75/752266/Lys_187/1'>The Receptor Binding Domain (RBD)</scene>.ALA 668 <scene name='75/752266/Ala_668/1'>Furin Cleavage site</scene>
+
== Relevance ==
 +
[[Image:CommonEasternFirefly.jpg|thumb|left|upright=1.8|The Common Eastern Firefly expressing bioluminescence seen giving off a yellow-green hue.[https://www.meigspointnaturecenter.org/today-is-firefly-day/]]]
-
</StructureSection>
+
Firefly luciferase has successfully been shown to act as modulatory bioluminescent indicator in the detection and quantification of protein kinase A activation in living cells <ref name="Newby">Sala-Newby, G. B., & Campbell, A. K. (1991). Engineering a bioluminescent indicator for cyclic AMP-dependent protein kinase. “The Biochemical Journal”, 279 (Pt 3), 727–732. https://doi.org/10.1042/bj2790727</ref>. Further, due to its bioluminescent sensitivity, firefly luciferase has been utilized in assays as a genetic reporter in eukaryotic cells<ref name="de">de Wet, J. R., Wood, K. V., DeLuca, M., Helinski, D. R., & Subramani, S. (1987). Firefly luciferase gene: structure and expression in mammalian cells. Molecular and cellular biology, 7(2), 725–737. https://doi.org/10.1128/mcb.7.2.725</ref><ref name="Escherichia">de Wet, J. R., Wood, K. V., Helinski, D. R., & DeLuca, M. (1985). Cloning of firefly luciferase cDNA and the expression of active luciferase in Escherichia coli. Proceedings of the National Academy of Sciences of the United States of America, 82(23), 7870–7873. https://doi.org/10.1073/pnas.82.23.7870</ref><ref name="Throne">Thorne, N., Shen, M., Lea, W. A., Simeonov, A., Lovell, S., Auld, D. S., & Inglese, J. (2012). Firefly luciferase in chemical biology: a compendium of inhibitors, mechanistic evaluation of chemotypes, and suggested use as a reporter. Chemistry & biology, 19(8), 1060–1072. https://doi.org/10.1016/j.chembiol.2012.07.015</ref>, amongst other things.
 +
 +
 +
 +
 +
</StructureSection>
== References ==
== References ==
 +
<references/>
<references/>

Current revision

Firefly Luciferase

Luciferin-4-monooxygenase. The wild-type luciferase in the adenylate-forming conformation with DLSA (PDB 4G36) and the cross-linked luciferase in the second catalytic conformation with DLSA (PDB 4G37)

Drag the structure with the mouse to rotate

References

  1. Branchini, B. R., Magyar, R. A., Murtiashaw, M. H., Anderson, S. M., Helgerson, L. C., & Zimmer, M. (1999). Site-directed mutagenesis of firefly luciferase active site amino acids: a proposed model for bioluminescence color. Biochemistry 38(40), 13223–13230. https://doi.org/10.1021/bi991181o
  2. 2.0 2.1 2.2 2.3 2.4 2.5 2.6 Sundlov, J. A., Fontaine, D. M., Southworth, T. L., Branchini, B. R., & Gulick, A. M. (2012). Crystal Structure of Firefly Luciferase in a Second Catalytic Conformation Supports a Domain Alternation Mechanism. Biochemistry 51(33), 6493-6495. https://doi.org/10.1021/bi300934s
  3. Marahiel, M. A., Stachelhaus, T., & Mootz, H. D. (1997). Modular Peptide Synthetases Involved in Nonribosmal Peptide Synthesis. Chemical Reviews 97(7), 2651-2674. https://doi.org/10.1021/cr960029e
  4. 4.0 4.1 Branchini, B. R., Southworth, T. L., Murtiahsaw, M. H., Wilkinson, S. R., Khattak, N. F., Rosenberg, J. C., & Zimmer, M. (2005). Mutagenesis Evidence that the Partial Reactions of Firefly Bioluminescence are Catalyzed by Different Conformations of the Luciferase C-Terminal Domain. “Biochemistry 44”(5), 1385-1393. https://doi.org/10.1021/bi047903f
  5. 5.0 5.1 5.2 Nakamura, M., Maki, S., Amano, Y., Ohkita, Y., Niwa, K., Hirano, T., Ohmiya, Y., & Niwa, H. (2005). Firefly luciferase exhibits bimodal action depending on the luciferin chirality. “Biochemical and Biophysical Research Communications, 331”(2), 471–475. https://doi.org/10.1016/j.bbrc.2005.03.202
  6. Oba, Y., Ojika, M., & Inouye, S. (2003). Firefly luciferase is a bifunctional enzyme: ATP-dependent monoxygenase and a long chain fatty acyl-CoA synthetase. “FEBS Letters 540”(1-3), 251-254. https://doi.org/10.1016/S0014-5793(03)00272-2
  7. Seliger, H. H., McElroy, W. D., White, E. H., & Field, G. F. (1961). Stereospecificity and firefly bioluminescence, a comparison of natural and synthetic luciferins. ‘’Proceedings of the National Academy of Sciences of the United States of America 47’’(8), 1129-1134. https://doi.org/10.1073/pnas.47.8.1129
  8. Lembert, N. (1996). Firefly luciferase can use L-luciferin to produce light. ‘’Biochemical Journal 317’’(1), 273-277. https://doi.org/10.1042/bj3170273
  9. Branchini, B. R., Murtiashaw, M. H., Magyar, R. A., Anderson, S. M. (2000). The Role of Lysine 529, a Conserved Residue of the Acyl-Adenylate-Forming Enzyme Superfamily, in Firefly Luciferase. Biochemistry 39(18), 5433-5440. https://doi.org/10.1021/bi9928804
  10. Sala-Newby, G. B., & Campbell, A. K. (1991). Engineering a bioluminescent indicator for cyclic AMP-dependent protein kinase. “The Biochemical Journal”, 279 (Pt 3), 727–732. https://doi.org/10.1042/bj2790727
  11. de Wet, J. R., Wood, K. V., DeLuca, M., Helinski, D. R., & Subramani, S. (1987). Firefly luciferase gene: structure and expression in mammalian cells. Molecular and cellular biology, 7(2), 725–737. https://doi.org/10.1128/mcb.7.2.725
  12. de Wet, J. R., Wood, K. V., Helinski, D. R., & DeLuca, M. (1985). Cloning of firefly luciferase cDNA and the expression of active luciferase in Escherichia coli. Proceedings of the National Academy of Sciences of the United States of America, 82(23), 7870–7873. https://doi.org/10.1073/pnas.82.23.7870
  13. Thorne, N., Shen, M., Lea, W. A., Simeonov, A., Lovell, S., Auld, D. S., & Inglese, J. (2012). Firefly luciferase in chemical biology: a compendium of inhibitors, mechanistic evaluation of chemotypes, and suggested use as a reporter. Chemistry & biology, 19(8), 1060–1072. https://doi.org/10.1016/j.chembiol.2012.07.015
Personal tools